Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sclero XIII factor XIII in systemic sclerosis
2014-001101-40Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing Factor XIII (Fibrogammin 1250) with Placebo (2 arms). Started Jan 2015; status: completed.
02
Drugs
Factor XIII (human)
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2014-001101-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001101-40.